数字农科院2.0

Huashi Runzao decoction for primary Sjögren disease: a double-blind, randomized controlled trial combined with m6A and m5C RNA modification analysis

文献类型： 外文期刊

作者： Ziwei Huang;Tiantian Deng;Xiya Zhang;Chunxin Lei;Yan Zhang;Jianying Yang;Qian He;Jiahe Liao;Jiaqi Chen、杨立文、谷晓峰、Jing Luo;Cheng Xiao;Qingwen Tao

作者机构：

关键词： Chinese medicine;Huashi Runzao decoction;randomized controlled trial;RNA methylation;Sjögren disease

期刊名称： Frontiers in Pharmacology

ISSN： 1663-9812

年卷期： 2025 年 16 卷

页码：

收录情况： SCIE（2025版）

摘要： Background: Huashi Runzao decoction (HRD), a Chinese herbal formula, has been used in clinical practice for patients with primary Sjögren disease (pSD) for years. However, the benefits of HRD for pSD have not been evaluated, and HRD epigenetic mechanism of action remains unexplored. Objectives: We conducted a double-blind, randomized, placebo-controlled clinical trial to evaluate the efficacy and safety of HRD in patients with pSD and to explore its epigenetic mechanism of action. Methods: The clinical scores (including oral dryness, dry eye, dryness, fatigue, and limb pain visual analogue scales scores and the ESSPRI) of pSD patients were recorded at baseline and every 4 weeks thereafter. The disease activity scores (including the ESSDAI and ClinESSDAI), exocrine gland function variables (including the result of Schirmer’s test and salivary flow rate), serological indices (ESR, CRP, IgG, IgA, and IgM) and short-form-36 health survey (SF-36) score were evaluated at baseline and 12 weeks later. Peripheral blood samples were collected from patients and healthy volunteers to determine RNA methylation (m6A and m5C) levels and analyse regulatory factor expression. Results: HRD improved exocrine gland function in pSD patients and increased saliva (P = 0.049) and tear (P = 0.005) secretion. It also improved patients’ perceptions of subjective symptoms, including oral dryness (P < 0.001), dry eye (P = 0.004), dryness (P = 0.001), and limb pain (P = 0.008) and yielded greater ESSPRIs (P = 0.001), reduced patients’ disease activity according to the ClinESSDAI (P = 0.038) and improved their quality of life. Moreover, HRD increased m6A levels and decreased m5C levels in pSD patients, and HNRNPA2B1 was identified as a potential key epigenetic regulator. Conclusion: HRD, a Chinese herbal medicine, may be a promising treatment for pSD, especially for glandular damage. The therapeutic effects of this decoction may be achieved by alteration of the HNRNPA2B1 gene, altering m6A and m5C levels in pSD patients.

分类号：

  • 相关文献

[1]Epigenetic modification for horticultural plant improvement comes of age. Sadaruddin Chachar,Muzafaruddin Chachar,Adeel Riaz,Aamir Ali Shaikh,Xiulan Li,Xiaoxue Li,Changfei Guan,Pingxian Zhang. 2022

[2]Effects Of Ultraviolet Radiation And H.igh Temperature On Total F lavonoids Content In Gnetum Parvifolium Warb. Deng, N, Liu, CX, Chen, W, Du, CJ, Chang, EM, Chen, LZ, Shi, SQ, Tian, YX, Jiang, ZP. 2018

[3]Effect of low-ratio n-6/n-3 PUFA on blood lipid level: a meta-analysis. Na Li,Min Jia,Qianchun Deng,Zhen Wang,Fenghong Huang,Hanxue Hou,Tongcheng Xu. 2021

[4]Cangpu Oral Liquid as a Possible Alternative to Antibiotics for the Control of Undifferentiated Calf Diarrhea. Wang, Shengyi,Cui, Dongan,Lv, Yanan,Yan, Zuoting,Zhang, Jiyu. 2022

[5]Effect of information intervention on enhancing the public payment scheme for agricultural plastic waste management. Aibo Hao,Changbin Yin,Thomas Dogot. 2025

作者其他论文 更多>>